MS DRUG

U.S. Supreme Court rebuffs Novartis, allows generic versions of MS drug

Novartis sued HEC and more than a dozen other generic drugmakers, accusing them of patent infringement, in Delaware federal court after they applied for U.S. Food and Drug Administration (FDA) approval of Gilenya generics.